Second‐Line Treatments for Kidney Cancer
Although most frontline combination regimens for advanced and metastatic clear cell renal…
Browsing Tag
SecondLine
Dolutegravir Switch Maintains Second-Line HIV Suppression
Switching people living with HIV from a ritonavir-boosted protease inhibitor…
Second-Line CAR-T Improves Survival in Large B-Cell Lymphoma
Treatment with the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel…
TTFields Therapy Yields OS Improvement in Second-Line NSCLC
CHICAGO -- Treatment with tumor treating field (TTFields) therapy combined with standard of care improved overall…
Second-Line Axi-Cel Bests Standard in Relapsed/Refractory Large B-Cell Lymphoma
CHICAGO -- Patients treated with the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel…
Second-Line Sacituzumab Govitecan Promising in Platinum-Ineligible UC
This year's Genitourinary Cancers Symposium featured multiple studies on established therapies and drugs…
Analysis of ctDNA Pinpoints Responders to Second-Line GIST Therapy
Circulating tumor DNA (ctDNA) analysis of KIT mutational status may be able to guide…
OS Benefit Eludes Second-Line Niraparib Maintenance in Ovarian Cancer
For women with platinum-sensitive recurrent ovarian cancer, maintenance therapy using an…
HUTCHMED Announces Positive Topline Result in Fruquintinib Phase III FRUTIGA Study in…
— Results of dual primary endpoint study showed statistically significant and clinically meaningful benefit in progression-free survival, a primary endpoint — — Overall survival, the other…
Targeted Agent Bests Chemo in Second-Line for KRAS-Mutant NSCLC
Targeted therapy with sotorasib (Lumakras) in previously treated non-small cell lung cancer (NSCLC)…